Nobivac Tricat Trio

Immunisation against FCV, FHV and FPLV.

Description

PDF Product Sheet NOBIVAC TRICAT TRIO

Composition

Per dose of 1ml :

Active substances : Lyophilisate
Live attenuated feline caicivirus, strain F9 > 4.6 log10 PFU1
Live attenuated feline herpes virus type 1, strain G2620A > 5.2 log10 PFU1
Live attenuatged feline panleukopenia virus, strain MW-1 >4.3 log10 CCID502
1PFU Plaque-forming units
2CCID50 Cell culture infective dose 50%
Indications

Active immunisation of cats:

– to reduce the clinical signs caused by infection with feline calicivirus (FCV) and feline herpes virus type 1 (FHV),

– to prevent the clinical signs, leucopoenia and virus excretion caused by infection with feline panleukopenia virus (FPLV)

Onset of immunity:

For FCV and FHV: 4 weeks, for FPLV: 3 weeks.

Duration of immunity:

For FCV and FHV: 1 year, for FPLV: 3 years